Insider · CIK 0001978220
Amresh Kumar
Files at GRCE (Grace Therapeutics, Inc.). First filing -, latest -.
Amresh Kumar files SEC Form 4 as officer at GRCE (Grace Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Amresh Kumar has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | GRCE Grace Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +35,760 | $0.00 | $0 | 35,760 | 42 d ago |
| Apr 14, 2025 | GRCE Grace Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Apr 16, 2025 |
Questions about Amresh Kumar
Answered from the filings on this page, as of the latest one.
Is Amresh Kumar buying or selling?
Amresh Kumar has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Amresh Kumar's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Amresh Kumar has 0.
Where does Amresh Kumar file Form 4?
Amresh Kumar has filed Form 4 at GRCE (Grace Therapeutics, Inc.) as VP Program Management. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.